Retrospective Evaluation of First-line Levetiracetam use for Neonatal Seizures after Congenital Heart Defect repair with or without Extracorporeal Membrane Oxygenation.

Keene, Jennifer C; Wainwright, Mark; Morgan, Lindsey A; Mietzsch, Ulrike; Musa, Ndidi; Bozarth, Xiuhua L; Natarajan, Niranjana

Keene, Jennifer C; Wainwright, Mark; Morgan, Lindsey A; Mietzsch, Ulrike; Musa, Ndidi; Bozarth, Xiuhua L; Natarajan, Niranjana.

Afiliación

Keene JC; University of Washington, Department of Neurology, Division of Child Neurology (JK, MW, LM, XB, NN), Seattle, WA.
Wainwright M; University of Washington, Department of Neurology, Division of Child Neurology (JK, MW, LM, XB, NN), Seattle, WA.
Morgan LA; University of Washington, Department of Neurology, Division of Child Neurology (JK, MW, LM, XB, NN), Seattle, WA.
Mietzsch U; Division of Neonatology (UM), Seattle, WA.
Musa N; Division of Pediatric Critical Care Medicine (NM), Seattle, WA.
Bozarth XL; University of Washington, Department of Neurology, Division of Child Neurology (JK, MW, LM, XB, NN), Seattle, WA.
Natarajan N; University of Washington, Department of Neurology, Division of Child Neurology (JK, MW, LM, XB, NN), Seattle, WA.

J Pediatr Pharmacol Ther ; 27(3): 254-262, 2022.

Article en En | MEDLINE | ID: mdl-35350164

Palabras clave

ECMO; anti-epileptic drug; anti-seizure medication; congenital heart defect; levetiracetam; neonatal seizures

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Pediatr Pharmacol Ther Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google